Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-117.82%Return on Assets
VS
Market
Sector
Industry
History
$ 6.47Close
$ 3.54 - $ 14.85 52-Week Range
Ticker Information
Ticker
KPTICompany Name
KARYOPHARM THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQKARYOPHARM THERAPEUTICS INC - Return on Assets Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
KPTI - ROA Historical data
| Date | Total Assets | Net Income Common Stock | Return on Assets |
|---|---|---|---|
| 6/30/2025 | $ 104.88M | $ -123.57M | -117.82% |
| 3/31/2025 | $ 127.71M | $ -62.52M | -48.96% |
| 12/31/2024 | $ 164.42M | $ -76.42M | -46.48% |
| 9/30/2024 | $ 189.48M | $ -87.48M | -46.17% |
| 6/30/2024 | $ 213.98M | $ -89.91M | -42.02% |
| 3/31/2024 | $ 204.46M | $ -146.34M | -71.57% |
| 12/31/2023 | $ 240.44M | $ -143.1M | -59.52% |
| 9/30/2023 | $ 269.96M | $ -139.77M | -51.77% |
| 6/30/2023 | $ 297.83M | $ -141.59M | -47.54% |
| 3/31/2023 | $ 325.8M | $ -158.02M | -48.5% |
Key Performance Insights, Last 5 Years
- KARYOPHARM THERAPEUTICS INC's latest trailing twelve months (TTM) ROA stands at -59.69%.
- Over the past 5 years, KARYOPHARM THERAPEUTICS INC's average ROA has been -56.57%.
- The median ROA for KARYOPHARM THERAPEUTICS INC during this period was -48.73%
- KARYOPHARM THERAPEUTICS INC reached its highest ROA over the past 5 years at -36.76%.
- The lowest ROA recorded by KARYOPHARM THERAPEUTICS INC in the same timeframe -117.82%
KARYOPHARM THERAPEUTICS INC's ROA vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROA Benchmarks
Similar metrics to ROA:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Equity - [Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
- Total Assets - [Balance Sheet] An asset represents anything that has current and/or future economic value to a company. This includes Cash [CashnEq], [Investments], [Intangibles], [Receivables] and more.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
Definition of Return on Assets
[Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.Net Inc. Cmn. / Assets
(=) ROA ROA for KARYOPHARM THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -201.5M ] / Assets [ $ 337.59M ]
(=) ROA [ -59.69% ] KPTI - Return on Assets, Last 5 years
-117.82%
Minimum
Jun 30, 2025
-36.76%
Maximum
Mar 31, 2022
-56.57%
Average
-48.73%
Median
ROA Benchmark AnalysisMarket
The chart above depicts the distribution of ROA for companies in the Total Stock Market. The average ROA of the companies is 0.09% with a standard deviation of 10.64%.
The following table provides additional summary stats:
ROA in the Market:
| filtered constituents | 3.45K |
|---|---|
| min | -33.42% |
| max | 33.98% |
| average | 0.09% |
| median | 1.52% |
| std | 10.64% |